EARNEST PARTNERS LLC - THRESHOLD PHARMACEUTICAL INC ownership

THRESHOLD PHARMACEUTICAL INC's ticker is THLD and the CUSIP is 885807206. A total of 87 filers reported holding THRESHOLD PHARMACEUTICAL INC in Q1 2015. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
EARNEST PARTNERS LLC ownership history of THRESHOLD PHARMACEUTICAL INC
ValueSharesWeighting
Q3 2015$28,0000.0%7,0000.0%0.00%
Q2 2015$28,0000.0%7,0000.0%0.00%
Q1 2015$28,000
+27.3%
7,0000.0%0.00%
Q4 2014$22,000
-12.0%
7,0000.0%0.00%
Q3 2014$25,000
-10.7%
7,0000.0%0.00%
Q2 2014$28,000
-15.2%
7,0000.0%0.00%
Q1 2014$33,000
-29.8%
7,000
-30.0%
0.00%
Q4 2013$47,00010,0000.00%
Other shareholders
THRESHOLD PHARMACEUTICAL INC shareholders Q1 2015
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 625,558$2,540,0001.95%
CG Asset Management LLC 128,000$520,0000.20%
Rotella Capital Management, Inc. 45,364$184,0000.15%
TFS CAPITAL LLC 348,617$1,415,0000.14%
Rhenman & Partners Asset Management AB 201,537$818,0000.14%
FORTALEZA ASSET MANAGEMENT INC/ 59,180$240,0000.14%
Baker Brothers Advisors 2,925,519$11,878,0000.10%
FEDERATED HERMES, INC. 3,918,305$15,908,0000.05%
FRANKLIN STREET ADVISORS INC /NC 50,000$203,0000.04%
Princeton Alpha Management LP 26,560$108,0000.02%
View complete list of THRESHOLD PHARMACEUTICAL INC shareholders